Literature DB >> 24973459

Pre- and postpandemic estimates of 2009 pandemic influenza A(H1N1) seroprotection to inform surveillance-based incidence, by age, during the 2013-2014 epidemic in Canada.

Danuta M Skowronski1, Catharine Chambers2, Suzana Sabaiduc1, Naveed Z Janjua1, Guiyun Li2, Martin Petric1, Mel Krajden1, Dale Purych3, Yan Li4, Gaston De Serres5.   

Abstract

To understand the epidemic resurgence of influenza due to the 2009 pandemic influenza A(H1N1) strain (A[H1N1]pdm09) during the 2013-2014 influenza season, we compared age-related cross-sectional estimates of seroprotection before the pandemic (during 2009) and after the pandemic (during 2010 and 2013) to subsequent surveillance-based, laboratory-confirmed incidence of influenza due to A(H1N1)pdm09 in British Columbia, Canada. Prepandemic seroprotection was negligible except for very old adults (defined as adults aged ≥ 80 years), among whom 80% had seroprotection. Conversely, postpandemic seroprotection followed a U-shaped distribution, with detection in approximately 35%-45% of working-aged adults but in ≥ 70% of very old adults and young children, excluding children aged <5 years in 2013, among whom seroprotection again decreased to <20%. The incidence was 5-fold higher during 2013-2014, compared with 2010-2011, and was highest among children aged <5 years and working-aged adults, reflecting a mirror image of the age-based seroprotection data.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  A(H1N1)pdm09; hemagglutination inhibition; incidence; influenza; seroprotection; serosurvey; surveillance

Mesh:

Substances:

Year:  2014        PMID: 24973459     DOI: 10.1093/infdis/jiu366

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

Review 1.  Influenza Vaccination in Older Adults: Recent Innovations and Practical Applications.

Authors:  Melissa K Andrew; Susan K Bowles; Graham Pawelec; Laura Haynes; George A Kuchel; Shelly A McNeil; Janet E McElhaney
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

2.  Anti-Human H1N1pdm09 and swine H1N1 Virus Antibodies among Swine Workers in Guangdong Province, China.

Authors:  Jie Wu; Lina Yi; Hanzhong Ni; Lirong Zou; Hongbin Zhang; Xianqiao Zeng; Lijun Liang; Laiqing Li; Haojie Zhong; Xin Zhang; Jin-yan Lin; Changwen Ke
Journal:  Sci Rep       Date:  2015-07-24       Impact factor: 4.379

3.  Avian Influenza A(H7N9) Virus Infection in 2 Travelers Returning from China to Canada, January 2015.

Authors:  Danuta M Skowronski; Catharine Chambers; Reka Gustafson; Dale B Purych; Patrick Tang; Nathalie Bastien; Mel Krajden; Yan Li
Journal:  Emerg Infect Dis       Date:  2016-01       Impact factor: 6.883

4.  2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project.

Authors:  Marc Rondy; Amparo Larrauri; Itziar Casado; Valeria Alfonsi; Daniela Pitigoi; Odile Launay; Ritva K Syrjänen; Giedre Gefenaite; Ausenda Machado; Vesna Višekruna Vučina; Judith Krisztina Horváth; Iwona Paradowska-Stankiewicz; Sierk D Marbus; Alin Gherasim; Jorge Alberto Díaz-González; Caterina Rizzo; Alina E Ivanciuc; Florence Galtier; Niina Ikonen; Aukse Mickiene; Veronica Gomez; Sanja Kurečić Filipović; Annamária Ferenczi; Monika R Korcinska; Rianne van Gageldonk-Lafeber; Marta Valenciano
Journal:  Euro Surveill       Date:  2017-07-27

5.  Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness?

Authors:  Catharine Chambers; Danuta M Skowronski; Caren Rose; Gaston De Serres; Anne-Luise Winter; James A Dickinson; Agatha Jassem; Jonathan B Gubbay; Kevin Fonseca; Steven J Drews; Hugues Charest; Christine Martineau; Martin Petric; Mel Krajden
Journal:  Open Forum Infect Dis       Date:  2018-09-04       Impact factor: 3.835

6.  Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: ‎possible cohort effect following the 2009 influenza pandemic.

Authors:  Danuta M Skowronski; Siobhan Leir; Gaston De Serres; Michelle Murti; James A Dickinson; Anne-Luise Winter; Romy Olsha; Matthew A Croxen; Steven J Drews; Hugues Charest; Christine Martineau; Suzana Sabaiduc; Nathalie Bastien; Yan Li; Martin Petric; Agatha Jassem; Mel Krajden; Jonathan B Gubbay
Journal:  Euro Surveill       Date:  2019-04

7.  Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.

Authors:  Danuta M Skowronski; Catharine Chambers; Suzana Sabaiduc; Gaston De Serres; Anne-Luise Winter; James A Dickinson; Jonathan B Gubbay; Steven J Drews; Christine Martineau; Hugues Charest; Mel Krajden; Nathalie Bastien; Yan Li
Journal:  J Infect Dis       Date:  2017-12-19       Impact factor: 5.226

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.